Elena Navarro‐Villarán

机构：Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Biomedicina de Sevilla, Universidad de Sevilla · ORCID：0000-0003-0765-9089

发表论文 31 篇 · 总被引 561 次 · h-index 12

代表论文

• Inhibition of the NLRP3 inflammasome prevents ovarian aging (2021 · Science Advances · 被引 187)
• Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer (2020 · Redox Biology · 被引 68)
• Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells (2020 · Cell Death and Disease · 被引 65)
• Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells (2018 · Journal of Cellular Physiology · 被引 60)
• Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells (2020 · Biochemical Pharmacology · 被引 32)
• Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAs (2021 · International Journal of Molecular Sciences · 被引 19)